This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

KNCV Tuberculosis Foundation Honors USAID For Eminence And Leadership In Global Fight Against Tuberculosis

WASHINGTON, March 21, 2013 /PRNewswire/ --

Today, on its 110th anniversary, KNCV Tuberculosis Foundation has honored the  U.S.  Agency for International Development (USAID) for its exceptional dedication and wise leadership in the worldwide fight against tuberculosis (TB).

Gerdy Schippers, Director of KNCV Tuberculosis Foundation:

"On this occasion we proudly recognize the USA's tremendous contribution towards winning the battle against tuberculosis. We have now set the stage for a healthy future in which we can eliminate this persistent disease by building on the achievements so far."

Dr. Ariel Pablos-Mendez, Assistant Administrator for Global Health, accepted the "Award for Eminence in TB Control" on behalf of USAID during a luncheon ceremony at the residence of the Dutch Ambassador in Washington D.C.. Once every five years KNCV Tuberculosis Foundation bestows this prize on a person or organization who has made an extraordinary contribution to the worldwide fight against TB. Prior recipients of the Award have been The National Tuberculosis Programs of Tanzania, Vietnam and Kenya.  

Gerdy Schippers expressed deep appreciation for USAID's catalytic, innovative and leading role, noting the agency's enduring commitment and exemplary leadership in curbing the rise of TB. USAID has been KNCV Tuberculosis Foundation's most important partner in the past 13 years; and thanks to this longstanding partnership the organization has contributed to the diagnosis and treatment of some 24 million tuberculosis patients worldwide.

In the coming years KNCV Tuberculosis Foundation will continue to pursue its mission towards globally eliminating TB and will give priority to:

  • introducing and scaling-up new diagnostic technologies and shorter treatment regimens (expected soon);
  • reversing the rise of multidrug-resistant TB;
  • working in close partnership with organizations fighting HIV/AIDS to increase access to integrated care for both diseases;
  • making a "shift to thrift" through sustainable planning and financing of TB programs, and by working with all tiers and disciplines of TB healthcare providers.

KNCV Tuberculosis Foundation is the principal international non-profit organization that is exclusively dedicated to and focused on fighting TB worldwide and to strengthening health systems against TB.

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs